These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24151976)

  • 21. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
    Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
    Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of the Tumour-Infiltrating Dendritic Cells in Colorectal Cancer: A Systematic Review.
    Malietzis G; Lee GH; Jenkins JT; Bernardo D; Moorghen M; Knight SC; Al-Hassi HO
    Cell Commun Adhes; 2015; 22(1):9-14. PubMed ID: 26027852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in situ local immune response, tumour senescence and proliferation in colorectal cancer.
    Roxburgh CS; Richards CH; Macdonald AI; Powell AG; McGlynn LM; McMillan DC; Horgan PG; Edwards J; Shiels PG
    Br J Cancer; 2013 Oct; 109(8):2207-16. PubMed ID: 24022192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.
    Di Caro G; Bergomas F; Grizzi F; Doni A; Bianchi P; Malesci A; Laghi L; Allavena P; Mantovani A; Marchesi F
    Clin Cancer Res; 2014 Apr; 20(8):2147-58. PubMed ID: 24523438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Importance of CD20
    Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
    Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer.
    Grimm M; Kim M; Rosenwald A; von Raden BH; Tsaur I; Meier E; Heemann U; Germer CT; Gasser M; Waaga-Gasser AM
    Eur J Cancer; 2010 Aug; 46(12):2314-23. PubMed ID: 20580220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.
    Bauer K; Michel S; Reuschenbach M; Nelius N; von Knebel Doeberitz M; Kloor M
    Fam Cancer; 2011 Sep; 10(3):557-65. PubMed ID: 21598004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the immune cell landscape in CRC: Clinical implications of tumour-infiltrating leukocytes in early- and late-stage CRC.
    Bazzi ZA; Sneddon S; Zhang PGY; Tai IT
    Front Immunol; 2022; 13():978862. PubMed ID: 36846019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
    Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
    Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
    Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
    Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
    Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
    Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study.
    Xiong Y; Wang K; Zhou H; Peng L; You W; Fu Z
    Cancer Med; 2018 Sep; 7(9):4496-4508. PubMed ID: 30117315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the notch signalling pathway are associated with enhanced anti-tumour immunity in colorectal cancer.
    Wang F; Long J; Li L; Zhao ZB; Wei F; Yao Y; Qiu WJ; Wu ZX; Luo QQ; Liu W; Quan YB; Lian ZX; Cao J
    J Cell Mol Med; 2020 Oct; 24(20):12176-12187. PubMed ID: 32924269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
    Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The density of infiltrating T cells and macrophages in the parental tumour correlates with growth rate of tumoroids established from colorectal adenocarcinoma.
    Mousavi N; Jespersen AJB; Jorgensen LN; Timmermans V; Heegaard S
    Int J Exp Pathol; 2019 Oct; 100(5-6):304-310. PubMed ID: 31997501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    Cantero-Cid R; Casas-Martin J; Hernández-Jiménez E; Cubillos-Zapata C; Varela-Serrano A; Avendaño-Ortiz J; Casarrubios M; Montalbán-Hernández K; Villacañas-Gil I; Guerra-Pastrián L; Peinado B; Marcano C; Aguirre LA; López-Collazo E
    BMC Cancer; 2018 Oct; 18(1):945. PubMed ID: 30285662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
    Roxburgh CS; McMillan DC
    Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?
    Cui G; Shi Y; Cui J; Tang F; Florholmen J
    Scand J Gastroenterol; 2012 Apr; 47(4):367-77. PubMed ID: 22229663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.